Cargando…
COVID-19 vaccine associated transverse myelitis-Evusheld as an option when vaccination is not recommended due to severe adverse events
Individuals who experience severe COVID-19-vaccine-related adverse reactions such as transverse myelitis may be precluded from receiving further vaccination to protect from SARS-CoV-2 infection. Although the mechanism of autoimmune spinal cord inflammation resulting in transverse myelitis is unclear...
Autor principal: | Fitzsimmons, William E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302530/ https://www.ncbi.nlm.nih.gov/pubmed/35511579 http://dx.doi.org/10.1080/21645515.2022.2068338 |
Ejemplares similares
-
SARS-CoV-2 vaccinations complicated by transverse myelitis
por: Finsterer, Josef
Publicado: (2022) -
Longitudinally extensive transverse myelitis after covid vaccination: Response to letter
por: Maroufi, Seyed Farzad, et al.
Publicado: (2022) -
Longitudinally extensive transverse myelitis after Covid-19 vaccination: case report and review of literature
por: Maroufi, Seyed Farzad, et al.
Publicado: (2022) -
The association between adverse events of COVID-19 vaccination and anxiety and willingness to receive a booster dose
por: Chen, Liling, et al.
Publicado: (2023) -
Single cell characteristics of patients with vaccine-related adverse reactions following inactivated COVID-19 vaccination
por: Jiang, Manling, et al.
Publicado: (2023)